Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram, mebeverine, and synbiotic for children with functional abdominal pain
ACTRN12613000158763Phase 3Active, not recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of citalopram, mebeverine, lactulose and Placebo-COD Research Private Ltd in functional abdominal pain (FAP) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Clinical Global Impression - Improvement (CGI-I), Clinical Global Impression - Severity (CGI-S) and 1 more. Started Mar 2013; status: active, not recruiting.
02
Drugs
citaloprammebeverinelactulosePlacebo-COD Research Private Ltd
03
Conditions
functional abdominal pain (FAP)
Beyond the preview
Go deeper on ACTRN12613000158763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000158763.